Winnaars MAB-scriptieprijs 2023 bekend

Winnaars MAB-scriptieprijs 2023 bekend

Een goede academische scriptie verdient het om extra in de spotlights te worden gezet. Het Maandblad voor Accountancy en Bedrijfseconomie (MAB) is daarom in 2023 gestart met de MAB-scriptieprijs. Doel hiervan is om sterke academische scripties met praktijkrelevantie te erkennen en te waarderen, door...

Full description

Bibliographic Details
Main Author:	Annemarie Oord
Format:	Article
Language:	English
Published:	Pensoft 2023-12-01
Series:	MAB
Subjects:	MAB-scriptieprijs winnaars
Online Access:	https://mab-online.nl/article/117624/download/pdf/

Similar Items

Winnaars MAB-scriptieprijs 2024 bekend
by: Annemarie Oord, et al.
Published: (2024-12-01)

M.A.B. Revestimientos vítreos con propiedades bactericidas y fungicidas
by: Yagüe Muñoz, A., et al.
Published: (2012-04-01)

Ranking mAb–excipient interactions in biologics formulations by NMR spectroscopy and computational approaches
by: Chunting Zhang, et al.
Published: (2023-12-01)

muMAB: A Multi-Armed Bandit Model for Wireless Network Selection
by: Stefano Boldrini, et al.
Published: (2018-01-01)

Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports
by: Mohan Hingorani, et al.
Published: (2014-12-01)

Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1
by: Masato Sano, et al.
Published: (2020-12-01)

Identification of Cis- and Trans-Acting Factors Regulating the Expression of the T-box Gene Mab-9
by: GhA Jafari, et al.
Published: (2005-10-01)

Identification of Cis- and Trans-Acting Factors Regulating the Expression of the T-box Gene Mab-9
by: GhA Jafari, et al.
Published: (2005-03-01)

Implementation of QbD strategies in the inoculum expansion of a mAb production process
by: Ole Jacob Böhl, et al.
Published: (2021-03-01)

Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins
by: Marlena Surowka, et al.
Published: (2021-01-01)

DFT-assisting discovery and characterization of a hexagonal MAB-phase V3PB4
by: Hang Yin, et al.
Published: (2023-11-01)

IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
by: Qiuxia Qu, et al.
Published: (2020-04-01)

Time-slot allocation algorithm for LEO satellite beam hopping based on non-stationary MAB
by: Min LIN, et al.
Published: (2023-08-01)

Time-slot allocation algorithm for LEO satellite beam hopping based on non-stationary MAB
by: Min LIN, et al.
Published: (2023-08-01)

Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg
by: Mepur H. Ravindranath, et al.
Published: (2021-06-01)

Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma
by: Samuel E Norton, et al.
Published: (2023-01-01)

Phase stability and mechanical property trends for MAB phases by high-throughput ab initio calculations
by: Nikola Koutná, et al.
Published: (2024-05-01)

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
by: Yuta Hara, et al.
Published: (2020-01-01)

Peter Bevers winnaar studentenaward
by: P. J. Bevers
Published: (2010-12-01)

Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980–2016)
by: Yunfeng Lai, et al.
Published: (2018-04-01)

SWATH-MS insights on sodium butyrate effect on mAbs production and redox homeostasis in CHO cells
by: Mauro Galli, et al.
Published: (2024-12-01)

Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer
by: Xiuying Li, et al.
Published: (2023-03-01)

A novel channel access algorithm based on clusters and MAB model in cognitive vehicular network
by: Fei PENG, et al.
Published: (2016-07-01)

A novel channel access algorithm based on clusters and MAB model in cognitive vehicular network
by: Fei PENG, et al.
Published: (2016-07-01)

Optimizing sequential treatment with anti-EGFR and VEGF mAb in metastatic colorectal cancer: current results and controversies
by: Chen DT, et al.
Published: (2019-02-01)

MAB21L1 modulates gene expression and DNA metabolic processes in the lens placode
by: Ryuichi Yamada, et al.
Published: (2021-12-01)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
by: Josée Golay, et al.
Published: (2020-10-01)

Treatment Patterns, Healthcare Resource Utilization, and Direct Costs Among Patients Initiating Concomitant Use of a Calcitonin Gene-Related Peptide Monoclonal Antibody (CGRP mAb) and Novel Acute Medication in the United States
by: Varnado OJ, et al.
Published: (2023-12-01)

Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
by: Léo Faïon, et al.
Published: (2023-02-01)

Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly
by: Mercè Farràs, et al.
Published: (2020-01-01)

Russian biosphere reserves at the youth MAB-2017 Forum in Italy
by: Elena A. Shuyskaya, et al.
Published: (2018-02-01)

Berend van der Kolk winnaar Studentenaward
by: MAB
Published: (2013-03-01)

Metastable phase formation of (Mo,Cr)2AlB2 MAB phase thin films revealed by theory and experiments
by: P. J. Pöllmann, et al.
Published: (2024-01-01)

Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus
by: Mengjun Li, et al.
Published: (2023-12-01)

Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus
by: Buhari Yusuf, et al.
Published: (2024-10-01)

How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca<sup>2+</sup>
by: Ronald P. Taylor, et al.
Published: (2020-09-01)

Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01)

Treatment of Hepatocellular Carcinoma by Intratumoral Injection of 125I-AA98 mAb and Its Efficacy Assessments by Molecular Imaging
by: Jun Zhou, et al.
Published: (2019-11-01)

Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
by: Nikolaj Siersbæk, et al.
Published: (2023-07-01)

Highly Active and Abundant MAB Phases Nin+1ZnBn (n = 1, 2) toward Hydrogen Evolution
by: Amir A. Rezaie, et al.
Published: (2021-09-01)